A detailed history of Rothschild Investment LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 150 shares of TGTX stock, worth $4,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Previous 80 87.5%
Holding current value
$4,185
Previous $1.42 Million 146.59%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$17.21 - $25.28 $1,204 - $1,769
70 Added 87.5%
150 $3.51 Million
Q2 2024

Jul 30, 2024

BUY
$13.32 - $19.19 $1,065 - $1,535
80 New
80 $1.42 Million
Q1 2024

Jul 31, 2024

SELL
$13.02 - $21.3 $911 - $1,491
-70 Reduced 87.5%
10 $152,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.05B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.